The pso Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the pso Hub cannot guarantee the accuracy of translated content. The pso and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB: For educational content and news updates.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View pso content recommended for you
Treatment preferences and unmet needs of patients with psoriasis in China
|
Results of a survey of 50 dermatologists and 300 patients with moderate-to-severe psoriasis (msPsO) from five regional dermatology centers in China have been published in Dermatology and Therapy by Kuang et al.1 The survey identified unmet needs and treatment preferences for the systematic treatment of patients with msPsO.
|
| Key learnings: |
|
Both dermatologists and patients with msPsO reported a preference for once-daily oral treatments over biweekly subcutaneous injections when efficacy and safety profiles were comparable. |
|
The primary reasons for discontinuation of oral systemic treatments were unsatisfactory effectiveness and treatment toxicity, while loss of efficacy over time and injection site reactions were significant issues for biologics. |
|
The study highlighted that traditional oral treatments remain the main systemic treatments for msPsO in China owing to their lower costs, with acitretin the most commonly used. |
| These findings suggest a need for more effective, safe, and convenient treatments that can maintain long-term efficacy, addressing the current unmet needs in the management of patients with msPsO in China. |
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
